Toward brain tumor gene therapy using multipotent mesenchymal stromal cell vectors

Area of Science:

• Oncology
• Gene Therapy
• Cellular Biology

Background:

• Gene therapy for solid tumors faces challenges due to limited vector distribution.
• Cellular vectors, particularly multipotent mesenchymal stromal cells (MSCs), offer a promising solution for invasive cancer gene delivery.
• MSCs exhibit tropism for various tumors, forming the basis for their use as gene vectors.

Purpose of the Study:

• To review the tumor-directed migratory potential and mechanisms of MSCs for cancer gene therapy.
• To focus on malignant gliomas as a model system for invasive, highly vascularized tumors.
• To discuss the choice of therapeutic transgenes for MSC-based cancer therapy.

Main Methods:

• Review of existing literature on MSC migration and gene delivery in cancer models.
• Analysis of MSC characteristics, including their similarity to pericytes and localization in perivascular tumor niches.
• Examination of potential concerns and therapeutic implications of using MSCs in cancer gene therapy.

Main Results:

• MSCs demonstrate effective migration and gene delivery to invasive tumors, including gliomas.
• MSCs share characteristics with pericytes and localize to tumor perivascular niches.
• Potential concerns include MSC contribution to tumor stroma/vasculature, immune suppression, and malignant transformation.

Conclusions:

• MSCs represent a promising cellular vector system for cancer gene therapy, particularly for invasive solid tumors.
• Understanding MSC migration mechanisms and addressing safety concerns are crucial for clinical translation.
• MSC-based tumor therapy offers novel prospects for treating challenging neoplasms.